Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Meiyu Quan

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5023038483. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2020: 3 papers · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 5

  1. ESE1/AGR2 axis antagonizes TGF-β-induced epithelial-mesenchymal transition in low-grade pancreatic cancer. Co-author DOI 10.1002/cam4.5397↗
  2. Yap1-2 Isoform Is the Primary Mediator in TGF-β1 Induced EMT in Pancreatic Cancer. First author DOI 10.3389/fonc.2021.649290↗
  3. An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness. Co-author DOI 10.3389/fcell.2020.00287↗
  4. Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness. Co-author DOI 10.3389/fcell.2020.594589↗
  5. The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy. First author DOI 10.7150/thno.42795↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin‐San Zhang · 5 shared papers, 2020–2023 · strength 0.55
  2. Jiayu Liu · 3 shared papers, 2020–2021 · strength 0.30
  3. Zhenkun Lou · 3 shared papers, 2020 · strength 0.28
  4. Qiang Guo · 3 shared papers, 2020 · strength 0.28
  5. Daniel D. Billadeau · 3 shared papers, 2020 · strength 0.28
  6. Huijing Xu · 2 shared papers, 2020–2023 · strength 0.25
  7. Jie Wang · 1 shared paper, 2023 · strength 0.16
  8. Chao Gao · 1 shared paper, 2021 · strength 0.11
  9. Wei Wang · 1 shared paper, 2020 · strength 0.09
  10. Li Ding · 1 shared paper, 2020 · strength 0.09
  11. Wei Wang · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.